Anika Therapeutics (ANIK) Cash from Operations Growth (1y) (2011 - 2026)
Powered by 
Analysis
Anika Therapeutics (ANIK) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 21.54% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 48.31% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 64.80% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 13.50% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 14.62% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 124.64% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 0.99% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -11.16% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -12.60% |
| 10 | Anika Therapeutics | 277.93 Mn | 239.52 Mn | 21.24 Mn | -261.90% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -261.90% |
| Mar 31, 2026 | -3,627.69% |
| Dec 31, 2025 | 193.11% |
| Sep 30, 2025 | 36.96% |
| Jun 30, 2025 | 82.32% |
| Mar 31, 2025 | -3.17% |
| Dec 31, 2024 | -56.51% |
| Sep 30, 2024 | -22.65% |
| Jun 30, 2024 | 87.11% |
| Mar 31, 2024 | 96.52% |
| Dec 31, 2023 | 656.34% |
| Sep 30, 2023 | 139.39% |
| Jun 30, 2023 | -368.56% |
| Mar 31, 2023 | -93.58% |
| Dec 31, 2022 | -89.24% |
| Sep 30, 2022 | 31.38% |
| Jun 30, 2022 | -28.09% |
| Mar 31, 2022 | 23.12% |
| Dec 31, 2021 | 72.86% |
| Sep 30, 2021 | -64.84% |